T-Squared Validair, a UK-based leader in regulatory compliance and certification for 'clean air' environments, has secured a contract with Sidra Medicine Hospital in Qatar.
This collaboration underscores T-Squared Validair's expertise in supporting high-quality cleanroom installations internationally.
Sidra Medicine is a 400-bed women's and children's hospital, medical education, and biomedical research centre in Doha, Qatar.
This acquisition enables the companies to combine their expertise in delivering specialised cleanrooms with compliance in mind from the beginning of the design process
T-Squared Validair
In August 2024, Validair joined the T-Squared group, a UK-based company that specialises in designing, building, and validating controlled environments like cleanrooms and laboratories, primarily for industries such as healthcare, pharmaceuticals, and biotechnology.
This acquisition enables the companies to combine their expertise in delivering specialised spaces with compliance in mind from the beginning of the design process.
This integration has also strengthened Validair's coverage across the UK and Ireland, with nine dedicated offices, and expanded its services across various industries, including life sciences, biotechnology, healthcare, pharmaceuticals, space, quantum, and specialist manufacturing.
Sidra Medicine became the first hospital in the country to administer revolutionary gene therapy for Duchenne Muscular Dystrophy
Sidra Medicine
T-Squared Validair's collaboration with Sidra Medicine highlights its commitment to delivering expert commissioning, qualification, and validation services to industries requiring the highest standards in controlled environments.
Additionally, Sidra Medicine has been at the forefront of medical advancements in Qatar.
Notably, Sidra Medicine became the first hospital in the country to administer revolutionary gene therapy for Duchenne Muscular Dystrophy (DMD).
Top image: Sidra Medicine Hospital